On the 1st of November 2019, VISUfarma, the eye-health company company which excels in bringing global innovation to Europe and commercialises a wide portfolio of products and devices across Europe, has appointed Mr. Fabrizio Giombini as their new Chief Executive Officer Europe (excl. Italy) and Managing Director for VISUfarma BV and VISUfarma SAS.
Former chief executive officer Mr. Tom van Haarlem will leave the company and will continue henceforth as Senior Advisor to the Board supporting the business in a different, non-executive role. In this new role, he will focus on ongoing Business Development and new product opportunities for VISUfarma.
Mr. Giombini possesses a strong strategic, commercial and change management background thanks to his extensive experience in different roles within the pharmaceutical industry. He has demonstrated a proven track record in transforming organizations, delivering outstanding results in complex health care environments, successfully launching new products and building high performing teams while establishing high level relationships with key customers and stakeholders.
VISUfarma is developing breakthrough technologies in ophthalmology based on a varied portfolio of products and devices. Additionally, VISUfarma has recently acquired well-established pharmaceutical products to compliment and expand their current offering in glaucoma. The Company fosters a unique network in the ophthalmology space which enables physicians, hospitals and medical centres to provide patients with the highest quality eye care.